Laboratory Reference Grade Compounds
Cognitive & Neuroprotective Peptides

Semax

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱3,150.00
In Stock · Dispatches 24h
Net Content10MG
InclusionVial + BAC Water
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose250 mcg – 500 mcg dailySyringe: 5.0 units (0.05 mL)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
✓ Includes 10mL Bacteriostatic Water USPMonograph SOP →
Semax10MG · Vial + BAC Water
₱3,150.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from a natural fragment of adrenocorticotropic hormone (ACTH 4-10) combined with a tripeptide stabilizer.

How it works: Semax acts on the central nervous system without producing any hormonal or steroid side effects. It dramatically boosts the expression of BDNF (Brain-Derived Neurotrophic Factor) and its TrkB receptor in the hippocampus, activates dopaminergic and serotonergic neurotransmission, and shields brain cells from glutamate excitotoxicity and oxygen deprivation.

Why researchers study it: Studied for cognitive enhancement, memory formation, rapid focus and mental processing, ischemic stroke recovery, ADHD research, and protecting the brain from stress and exhaustion.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryCognitive & Neuroprotective
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number80714-61-0
PubChem CID9811102↗
Molecular Weight813.92 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options5MG, 10MG, 30MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaMet-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
⚡ Pharmacodynamic Synergy·Verified Stacking Regimens

Frequently Stacked with Semaglutide

Clinically verified combinations activating complementary physiological pathways without receptor competition.

Stacking Studio
Co-Administered Regimen

Cagrilintide (Amylin Analogue)

+99 Synergy
The CagriSema Protocol: Coordinated Amylin + GLP-1 Incretin Synergy

Cagrilintide engages area postrema and ventral tegmental amylin receptors while Semaglutide stimulates hypothalamic GLP-1 receptors, producing multiplicative appetite suppression and glycemic control superior to either monotherapy.

⏱Co-administered once weekly on the same day•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

BPC-157 (Pentadecapeptide)

+90 Synergy
GLP-1 Gut Barrier & Epithelial Recovery Stack

Semaglutide delays gastric motility to enhance satiety. BPC-157 upregulates tight junction proteins (Claudin, Zonula Occludens) and nitric oxide synthesis, minimizing digestive cramping and acid reflux in GLP-1 naive subjects.

⏱Semaglutide: Weekly SubQ•🛡Separate syringe
15% Off bundle
Compare
⚠️ Critical Safety Contraindication Warning:
Semaglutide is contraindicated to stack concurrently with Tirzepatide, Retatrutide. Both agents compete for the same receptor beds, risking severe adverse compounding without additive efficacy.